blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2791137

EP2791137 - PYRAZOLOPYRIDINE DERIVATIVES, PREPARATION PROCESS THEREFOR AND THERAPEUTIC USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.12.2019
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  21.12.2018
FormerGrant of patent is intended
Status updated on  22.08.2018
FormerExamination is in progress
Status updated on  20.07.2018
FormerGrant of patent is intended
Status updated on  15.04.2018
FormerExamination is in progress
Status updated on  09.01.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
SANOFI
54, rue La Boétie
75008 Paris / FR
[2019/04]
Former [2014/43]For all designated states
SANOFI
54, rue La Boétie
75008 Paris / FR
Inventor(s)01 / ALCOUFFE, Chantal
c/o Sanofi
Patent Department
54 rue La Boétie
F-75008 Paris / FR
02 / BJEGARDE, Kirsten
c/o Sanofi
55 Corporate Drive
Mail Code 55A-505A
Bridgewater, NJ 08807 / US
03 / MAUGER, Jacques
c/o Sanofi
55 Corporate Drive
Mail Code 55A-505A
Bridgewater, NJ 08807 / US
 [2014/43]
Representative(s)Cabinet Nony
11 rue Saint-Georges
75009 Paris / FR
[N/P]
Former [2019/04]Nony
11 rue Saint-Georges
75009 Paris / FR
Former [2014/43]Catillon, Marie
Sanofi
Département Brevets
54, rue La Boétie
75008 Paris / FR
Application number, filing date12808328.413.12.2012
[2019/04]
WO2012EP75328
Priority number, dateFR2011006158914.12.2011         Original published format: FR 1161589
[2014/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013087744
Date:20.06.2013
Language:EN
[2013/25]
Type: A1 Application with search report 
No.:EP2791137
Date:22.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 20.06.2013 takes the place of the publication of the European patent application.
[2014/43]
Type: B1 Patent specification 
No.:EP2791137
Date:23.01.2019
Language:EN
[2019/04]
Search report(s)International search report - published on:EP20.06.2013
ClassificationIPC:C07D471/04, A61K31/437, A61P35/00, A61P35/04
[2014/43]
CPC:
A61K31/538 (EP,US); C07D471/04 (EP,CN,US); A61K31/437 (EP,CN,US);
A61K31/444 (EP,CN,US); A61K31/4545 (EP,CN,US); A61K31/5355 (CN);
A61K31/536 (CN); A61K31/5377 (EP,US); A61K45/06 (CN,US);
A61N5/10 (US); A61P35/00 (EP,US); A61P35/04 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/43]
Extension statesBA14.07.2014
ME14.07.2014
TitleGerman:PYRAZOLOPYRIDINDERIVATE, HERSTELLUNGSVERFAHREN DAFÜR UND THERAPEUTISCHE VERWENDUNG DAVON[2014/43]
English:PYRAZOLOPYRIDINE DERIVATIVES, PREPARATION PROCESS THEREFOR AND THERAPEUTIC USE THEREOF[2014/43]
French:DÉRIVÉS DE PYRAZOLOPYRIDINE, PROCÉDÉ D'ÉLABORATION DE CES DÉRIVÉS, ET UTILISATION THÉRAPEUTIQUE DE CEUX-CI[2014/43]
Entry into regional phase14.07.2014National basic fee paid 
14.07.2014Designation fee(s) paid 
14.07.2014Examination fee paid 
Examination procedure14.07.2014Examination requested  [2014/43]
28.01.2015Amendment by applicant (claims and/or description)
20.04.2015Despatch of a communication from the examining division (Time limit: M06)
14.09.2015Reply to a communication from the examining division
12.10.2015Despatch of a communication from the examining division (Time limit: M04)
19.01.2016Reply to a communication from the examining division
29.01.2016Despatch of a communication from the examining division (Time limit: M04)
24.03.2016Reply to a communication from the examining division
15.04.2016Despatch of a communication from the examining division (Time limit: M04)
29.07.2016Reply to a communication from the examining division
13.09.2016Despatch of a communication from the examining division (Time limit: M06)
31.01.2017Reply to a communication from the examining division
06.03.2017Despatch of a communication from the examining division (Time limit: M04)
05.05.2017Reply to a communication from the examining division
23.06.2017Despatch of a communication from the examining division (Time limit: M02)
27.06.2017Reply to a communication from the examining division
14.07.2017Despatch of a communication from the examining division (Time limit: M04)
12.09.2017Reply to a communication from the examining division
16.04.2018Communication of intention to grant the patent
19.07.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
23.08.2018Communication of intention to grant the patent
05.12.2018Fee for grant paid
05.12.2018Fee for publishing/printing paid
05.12.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.04.2015
Opposition(s)24.10.2019No opposition filed within time limit [2020/01]
Fees paidRenewal fee
11.12.2014Renewal fee patent year 03
10.12.2015Renewal fee patent year 04
13.12.2016Renewal fee patent year 05
12.12.2017Renewal fee patent year 06
12.12.2018Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.12.2012
AL23.01.2019
CY23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
MC23.01.2019
MK23.01.2019
MT23.01.2019
RO23.01.2019
RS23.01.2019
SI23.01.2019
SK23.01.2019
SM23.01.2019
TR23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
[2022/31]
Former [2021/34]HU13.12.2012
AL23.01.2019
CY23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
MC23.01.2019
MT23.01.2019
RO23.01.2019
RS23.01.2019
SI23.01.2019
SK23.01.2019
SM23.01.2019
TR23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2021/33]HU13.12.2012
AL23.01.2019
CY23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
MC23.01.2019
RO23.01.2019
RS23.01.2019
SI23.01.2019
SK23.01.2019
SM23.01.2019
TR23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2021/26]AL23.01.2019
CY23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
MC23.01.2019
RO23.01.2019
RS23.01.2019
SI23.01.2019
SK23.01.2019
SM23.01.2019
TR23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2020/39]AL23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
MC23.01.2019
RO23.01.2019
RS23.01.2019
SI23.01.2019
SK23.01.2019
SM23.01.2019
TR23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2020/17]AL23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
RO23.01.2019
RS23.01.2019
SI23.01.2019
SK23.01.2019
SM23.01.2019
TR23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2020/13]AL23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
RO23.01.2019
RS23.01.2019
SI23.01.2019
SK23.01.2019
SM23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2019/52]AL23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
RO23.01.2019
RS23.01.2019
SK23.01.2019
SM23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2019/49]AL23.01.2019
CZ23.01.2019
EE23.01.2019
HR23.01.2019
LT23.01.2019
LV23.01.2019
RO23.01.2019
RS23.01.2019
SK23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2019/39]HR23.01.2019
LT23.01.2019
LV23.01.2019
RS23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
IS23.05.2019
Former [2019/38]LT23.01.2019
BG23.04.2019
NO23.04.2019
GR24.04.2019
Former [2019/37]LT23.01.2019
NO23.04.2019
GR24.04.2019
Former [2019/33]LT23.01.2019
NO23.04.2019
Cited inInternational search[A]WO2006050076  (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1-17 * claim 1 *;
 [A]WO2006124863  (IRM LLC [US], et al) [A] 1-17 * claim 1 *;
 [A]WO2006130673  (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1-17 * claim 1 *;
 [A]WO2008028617  (HOFFMANN LA ROCHE [CH], et al) [A] 1-17 * claim 1 *;
 [A]US2008182844  (BJERGARDE KIRSTEN [US], et al) [A] 1-17* claim 1 *;
 [A]US2009030010  (SCHWEDE WOLFGANG [DE], et al) [A] 1-17 * claim 1 *;
 [A]WO2009038385  (CHOONGWAE PHARMA CORP [KR], et al) [A] 1-17 * claim 1 *;
 [A]WO2010078427  (ARQULE INC [US], et al) [A] 1-17 * claim 1 *;
 [A]WO2011045344  (PF MEDICAMENT [FR], et al) [A] 1-17 * claim 1 *
ExaminationWO2009069032
    - CHEBANOV V. A. ET AL., "Cyclocondensation reactions of 5-aminopyrazoles, pyruvic acids and aldehydes. Multicomponent approaches to pyrazolopyridines and related products", TETRAHEDRON, (20061211), vol. 63, doi:doi:10.1016/j.tet.2006.11.048, pages 1229 - 1242, XP005811221

DOI:   http://dx.doi.org/10.1016/j.tet.2006.11.048
by applicant   - GREENE ET AL., Protective Groups in Organic Synthesis, JOHN WILEY & SONS, INC
    - POLISH JOURNAL OF CHEMISTRY, (1983), vol. 57, page 789
    - KESHET E.; BEN-SASSON S.A., J. CLIN. INVEST, (1999), vol. 501, pages 104 - 1497
    - PRESTA M.; RUSNATI M.; DELL'ERA P.; TANGHETTI E.; URBINATI C.; GIULIANI R. ET AL., J. CLIN. INVEST, PLENUM PUBLISHERS, (2000), pages 7 - 34
    - BILLOTTET C.; JANJI B.; THIERY J.P.; JOUANNEAU J., ONCOGENE, (2002), vol. 21, pages 8128 - 8139
    - CHANDLER L.A.; SOSNOWSKI B.A.; GREENLEES L.; AUKERMAN S.L.; BAIRD A.; PIERCE G.F., INT. J. CANCER, (1999), vol. 58, pages 81 - 451
    - GIRI D.; ROPIQUET F., CLIN. CANCER RES., (1999), vol. 71, pages 5 - 1063
    - DOLL J.A.; REIHER F.K.; CRAWFORD S.E.; PINS M.R.; CAMPBELL S.C.; BOUCK N.P., PROSTATE, (2001), vol. 305, pages 49 - 293
    - VERCOUTTER-EDOUART A-S; CZESZAK X; CREPIN M; LEMOINE J; BOILLY B; LE BOURHIS X ET AL., EXP.CELL RES., (2001), vol. 262, pages 59 - 68
    - YAYON A.; MA Y-S; SAFRAN M.; KLAGSBRUN M.; HALABAN R., ONCOGENE, (1997), vol. 14, pages 2999 - 3009
    - YAMADA S.M.; YAMAGUCHI F.; BROWN R.; BERGER M.S.; MORRISON R.S., GLIA, (1999), vol. 76, pages 28 - 66
    - AUGUSTE P.; GURSEL D.B.; LEMIERE S.; REIMERS D.; CUEVAS P.; CARCELLER F. ET AL., CANCER RES., (2001), vol. 26, pages 61 - 1717
    - THOMAS D.A.; GILES F.J.; CORTES J.; ALBITAR M.; KANTARJIAN H.M., ACTA HAEMATOL., (2001), vol. 207, pages 106 - 190
    - GABRILOVE J.L., ONCOLOGIST, (2001), vol. 6, pages 4 - 7
    - EPSTEIN C.E.; SIEGALL C.B.; BIRO S; FU Y.M.; FITZGERALD D., CIRCULATION, (1991), vol. 87, pages 84 - 778
    - WALTENBERGER J., CIRCULATION, (1997), pages 96 - 4083
    - SCHULTZ JEJ; WITT S.A.; NIEMAN M.L.; REISER P.J.; ENGLE S.J.; ZHOU M. ET AL., J.CLIN. INVEST., (1999), vol. 19, pages 104 - 709
    - TILTON R.G.; DIXON R.A.F.; BROCK T.A., EXP. OPIN. INVEST. DRUGS, (1997), vol. 84, pages 6 - 1671
    - YAMASHITA A; YONEMITSU Y; OKANO S; NAKAGAWA K; NAKASHIMA Y; IRISA T ET AL., J. IMMUNOL., (2002), vol. 57, pages 168 - 450
    - MANABE N; ODA H; NAKAMURA K; KUGA Y; UCHIDA S; KAWAGUCHI H, RHEUMATOL, (1999), vol. 20, pages 38 - 714
    - WALSH D.A., CURR. OPIN. RHEUMATOL., (200409), vol. 16, no. 5, pages 609 - 15
    - KANAZAWA S; TSUNODA T; ONUMA E; MAJIMA T; KAGIYAMA M; KKUCHI K, AMERICAN JOURNAL OF GASTROENTEROLOGY, (2001), vol. 28, pages 96 - 822
    - THORN M; RAAB Y; LARSSON A; GERDIN B; HALLGREN R, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, (2000), vol. 12, pages 35 - 408
    - CHEN L.; ADAR R.; YANG X.; MONSONEGO E.O.; LI C.; HAUSCHKA P.V.; YAGON A.; DENG C.X., THE JOURN. OF CLIN. INVEST., (1999), vol. 104, no. 11, pages 1517 - 1525
    - RUPNICK M.A. ET AL., PNAS, (2002), vol. 99, no. 16, pages 10730 - 10735
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.